The immunophenotypic characteristics and flow cytometric scoring system of acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1

被引:14
作者
Shang, Lei [1 ,2 ,3 ]
Chen, Xuejing [1 ,2 ,3 ]
Liu, Yan [1 ,2 ,3 ]
Cai, Xiaojin [1 ,2 ,3 ]
Shi, Yin [1 ,2 ,3 ]
Shi, Lihui [1 ,2 ,3 ]
Li, Yuanyuan [1 ,2 ,3 ]
Song, Zhen [2 ,3 ,4 ]
Zheng, Bin [1 ,2 ,3 ]
Sun, Wanchen [1 ,2 ,3 ]
Ru, Kun [1 ,2 ,3 ]
He, Yingchang [2 ,3 ,5 ]
Wang, Jianxiang [2 ,3 ,5 ]
Wang, Huijun [1 ,2 ,3 ]
机构
[1] Chinese Acad Med Sci, Dept Hematopathol, Inst Hematol, 288 Nanjing Rd, Tianjin, Peoples R China
[2] Chinese Acad Med Sci, Blood Dis Hosp, 288 Nanjing Rd, Tianjin, Peoples R China
[3] Peking Union Med Coll, 288 Nanjing Rd, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Med Serv Div, Inst Hematol, Tianjin, Peoples R China
[5] Chinese Acad Med Sci, Leukemia Ctr, Inst Hematol, Tianjin, Peoples R China
关键词
acute myeloid leukemia; flow cytometric scoring system; immunophenotype; t(8; 21); ACUTE MYELOBLASTIC-LEUKEMIA; CYTOGENETIC PROFILE; RISK STRATIFICATION; ANTIGEN-EXPRESSION; FUSION TRANSCRIPT; SURFACE-MARKERS; MUTATIONS; TRANSPLANTATION; PERSISTENCE; GENOTYPE;
D O I
10.1111/ijlh.12916
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The translocation t(8;21) is one of the most frequent chromosome translocations in AML. Molecular (cyto)genetics is regarded as the gold standard for diagnosis. However, due to the complicated variety of AML-related genetic abnormalities, comprehensive screening for all of these abnormalities may not be cost-effective. Therefore, a flow cytometric (FC) scoring system was generated in this study for rapid screening and diagnosis of t(8;21)AML. Methods The immunophenotypic characteristics of leukemic cells and neutrophils in cases with t(8;21) AML or other subtypes of AML were analyzed to find a method for the flow diagnosis of t(8;21) AML. Results In this study, we picked six FC features pointing to the diagnosis of t(8;21) AML: The blasts show high-intensity expression of CD34; aberrant expression of CD19, cCD79a, and CD56 in myeloblasts; co-expression of CD56 in neutrophils, especially in immature neutrophils; and a maturity disturbance in granulocytes. A six-point score was devised using these features. By ROC analysis, the AUC was 0.952, and the sensitivity, specificity, PPV, and NPV were 0.86, 0.90. 0.91, and 0.84 when the score was >= 3 points. The score was then prospectively validated on an independent cohort, and the AUC of the ROC curve for the validation cohort was 0.975. When the cutoff value was set at 3, the obtained sensitivity and specificity values were 0.91 and 0.94, respectively. Conclusions The FC score described can be used for the identification and rapid screening of t(8;21) AML.
引用
收藏
页码:23 / 31
页数:9
相关论文
共 50 条
  • [41] Pediatric acute myeloid leukemia with t(7;21)(p22;q22)
    Paulraj, Prabakaran
    Diamond, Steven
    Razzaqi, Faisal
    Ozeran, J. Daniel
    Longhurst, Maria
    Andersen, Erica F.
    Toydemir, Reha M.
    Hong, Bo
    GENES CHROMOSOMES & CANCER, 2019, 58 (08) : 551 - 557
  • [42] Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia
    G-Y Hung
    T-J Chiou
    Y-L Hsieh
    P-M Chen
    B Hwang
    Bone Marrow Transplantation, 2002, 29 : 67 - 70
  • [43] A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia
    Fu, Lin
    Shi, Jinlong
    Liu, Anqi
    Zhou, Lei
    Jiang, Mengmeng
    Fu, Huaping
    Xu, Keman
    Li, Dandan
    Deng, Ailing
    Zhang, Qingyi
    Pang, Yifan
    Guo, Yujie
    Hu, Kai
    Zhou, Jiansuo
    Wang, Yapeng
    Huang, Wenrong
    Jing, Yu
    Dou, Liping
    Wang, Lili
    Xu, Kailin
    Ke, Xiaoyan
    Nervi, Clara
    Li, Yonghui
    Yu, Li
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (03) : 653 - 661
  • [44] Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera
    Maki, Kazuhiro
    Sasaki, Ko
    Sugita, Fusako
    Nakamura, Yuka
    Mitani, Kinuko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (02) : 268 - 273
  • [45] RUNX1-MTG16 fusion gene in de novo acute myeloblastic leukemia with t(16;21)(q24;q22)
    Athanasiadou, Anastasia
    Stalika, Evagelia
    Sidi, Vasiliki
    Papaioannou, Maria
    Gaitatzi, Maria
    Anagnostopoulos, Achilles
    LEUKEMIA & LYMPHOMA, 2011, 52 (01) : 145 - 147
  • [46] Near-tetraploidy Acute Myeloid Leukemia with RUNX1-RUNX1T1 Rearrangement Due to Cryptic t(8;21)
    Im, Mijeong
    Lee, Jin Kyung
    Lee, Dong Young
    Hong, Young Joon
    Hong, Seok-Il
    Kang, Hye Jin
    Chang, Yoon Hwan
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2009, 29 (06): : 510 - 514
  • [47] CLCA2, a novel RUNX1 partner gene in a therapy-related leukemia with t(1;21)(p22;q22)
    Giguere, Amelie
    Hebert, Josee
    CANCER GENETICS AND CYTOGENETICS, 2010, 202 (02) : 94 - 100
  • [48] Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): An additional deletion in 9q is an adverse prognostic factor
    Schoch, C
    Haase, D
    Haferlach, T
    Gudat, H
    Buchner, T
    Freund, M
    Link, H
    Lengfelder, E
    Wandt, H
    Sauerland, MC
    Loffler, H
    Fonatsch, C
    LEUKEMIA, 1996, 10 (08) : 1288 - 1295
  • [49] Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion
    Panagopoulos, Ioannis
    Gorunova, Ludmila
    Brandal, Petter
    Garnes, Margaret
    Tierens, Anne
    Heim, Sverre
    ONCOLOGY REPORTS, 2013, 30 (04) : 1549 - 1552
  • [50] Pericentric chromosome 8 inversion, inv(8)(p11.2q22), associated with RUNX1/RUNX1T1 rearrangement in acute myeloid leukemia
    Yamamoto, Katsuya
    Okamura, Atsuo
    Yakushijin, Kimikazu
    Matsuoka, Hiroshi
    Minami, Hironobu
    ANNALS OF HEMATOLOGY, 2013, 92 (03) : 403 - 405